Boserolimab

DB17452InvestigationalProtein Based Therapies

Boserolimab: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin G1-kappa, anti-(homo sapiens CD27 (TNFRSF7, tumor necrosis factor receptor (TNFR) superfamily member 7))
Code names
MK-5890

Resolves to

Compound
UNII576SCZ7V2PCAS2444297-08-7
Targets
P26842CD27

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Boserolimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In